Category: St. Jude MedicalSyndicate content

St. Jude Medical hits 'pause' on Portico TAVI device

September 15, 2014 by Brad Perriello

St. Jude Medical hits 'pause' on implantations of its Portico replacement heart valve after CT scans turned up a potential problem with the devices.

St. Jude Medical hits 'pause' on Portico TAVI trial

Failure of Medtronic's Symplicity-3 trial doesn't mean the end of renal denervation for hypertension | Medtech Wall Street news for the week of September 1, 2014

September 4, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Renal denervation isn't dead, despite Medtronic trial's failure; Baxter says HQ will stay in Illinois, stays coy on Boston plans; Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

St. Jude cries victory with its quadripolar leads

September 4, 2014 by Arezu Sarvestani

St. Jude Medical says that its Quartet quadripolar leads "performed better than bipolar leads of any kind" in a recent mega-study.

St. Jude cries victory with its quadripolar leads

Medical device giant St. Jude Medical (NYSE:STJ) had high praise for its own quadripolar leads, saying that blow away any competition from older bipolar leads.

Medtech trends: The most talked about device makers in August 2014

September 3, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Study: St. Jude's FFR helps boost stenting over drug therapy alone

September 2, 2014 by Arezu Sarvestani

Researchers report that St. Jude Medical's fractional flow reserve technology helps slash adverse events, especially urgent revascularizations, compared with medical therapy alone.

Study: St. Jude's FFR tech helps cut adverse events in half

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.

Renal denervation isn't dead, despite Medtronic trial's failure

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Judge agrees to toss ex-Biosense rep's suit in non-compete row with St. Jude Medical

August 27, 2014 by Brad Perriello

A federal judge agrees to toss a lawsuit filed against Johnson & Johnson's Biosense Webster by a former sales rep and her new employer, St. Jude Medical.

Judge agrees to toss ex-Biosense rep's suit in non-compete row with St. Jude Medical
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp